Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha)

Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha)

US Patent 11938201 · Granted Mar 26, 2024

Estimated economic value: $39,208,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Uracil derivatives for stimulating read-through of premature termination codons2025
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2025
Methods and related aspects for pathology prognosis2024
Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (2024
Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (2024
Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (2024
Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (2024
Imaging and radiotherapeutics agents targeting fibroblast-activation protein-α (2024
PSMA-based molecular-genetic reporter system2024
PSMA-binding agents and uses thereof2024
PSMA targeted fluorescent agents for image guided surgery2024
Attenuated strain of African swine fever virus (ASFV) with IPTG-induced deletion2024